1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
75.67%
Revenue growth above 1.5x FSLR's 13.35%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
139.12%
Gross profit growth above 1.5x FSLR's 62.92%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
505.40%
EBIT growth above 1.5x FSLR's 137.85%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
616.64%
Operating income growth above 1.5x FSLR's 137.85%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
320.55%
Net income growth above 1.5x FSLR's 117.09%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
329.17%
EPS growth above 1.5x FSLR's 117.05%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
315.00%
Diluted EPS growth above 1.5x FSLR's 117.24%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.14%
Share count expansion well above FSLR's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-1.82%
Reduced diluted shares while FSLR is at 0.09%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
477.41%
OCF growth under 50% of FSLR's 2065.64%. Michael Burry might suspect questionable revenue recognition or rising costs.
156.59%
FCF growth under 50% of FSLR's 822.85%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
10938.99%
10Y revenue/share CAGR at 75-90% of FSLR's 12751.01%. Bill Ackman would press for new markets or product lines to narrow the gap.
53.87%
5Y revenue/share CAGR above 1.5x FSLR's 30.93%. David Dodd would look for consistent product or market expansions fueling outperformance.
53.69%
3Y revenue/share CAGR above 1.5x FSLR's 31.05%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
4077.42%
OCF/share CAGR of 4077.42% while FSLR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-4.71%
Negative 5Y OCF/share CAGR while FSLR is at 86.80%. Joel Greenblatt would question the firm’s operational model or cost structure.
-32.03%
Negative 3Y OCF/share CAGR while FSLR stands at 7322.57%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
821.32%
Below 50% of FSLR's 2072.79%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
10067.98%
5Y net income/share CAGR above 1.5x FSLR's 12.90%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
220.60%
3Y net income/share CAGR above 1.5x FSLR's 139.89%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-19.49%
Negative 5Y equity/share growth while FSLR is at 57.86%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-10.49%
Negative 3Y equity/share growth while FSLR is at 18.46%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.06%
Our AR growth while FSLR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
6.77%
Inventory shrinking or stable vs. FSLR's 15.35%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-1.43%
Negative asset growth while FSLR invests at 4.42%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
10.92%
BV/share growth above 1.5x FSLR's 4.84%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
7.10%
We have some new debt while FSLR reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
31.43%
We increase R&D while FSLR cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
8.93%
SG&A growth well above FSLR's 6.67%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.